series-a
Stage
About
AlphaGen Therapeutics develops next-generation targeted alpha and beta radioligand therapies for cancer treatment, leveraging proprietary Pb-212 isotope isolation technology to improve therapeutic efficacy and patient outcomes in China and globally.
Explore AlphaGen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.